Insider holders · CIK 0001109196
MABVAX THERAPEUTICS HOLDINGS, INC. · MBVX
Every insider with a reported Table I holding at this company, ranked by their last-reported share count. A balance is only as fresh as its filing — the report date sits next to every row on purpose. ← Back to activity
| Insider | Direct shares | Indirect shares | Total reported | Last report (ET) | From |
|---|---|---|---|---|---|
| Philip O. LivingstonChief Science Officer | 256,554 | 12,734 | 269,288 | Jan 16, 2018 · 6:00 am EST | Form 4 |
| John David HansenPRESIDENT AND CEO | 190,827 | — | 190,827 | Apr 3, 2018 · 6:23 pm EDT | Form 4 |
| Gregory P HansonCHIEF FINANCIAL OFFICER, SECR | 114,307 | — | 114,307 | Apr 3, 2018 · 6:24 pm EDT | Form 4 |
| Wolfgang W. ScholzVP OF ANTIBODY DISCOVERY | 113,288 | — | 113,288 | Apr 5, 2016 · 6:01 pm EDT | Form 4 |
| Paul W MaffuidEXEC. VP, R AND D | 99,877 | — | 99,877 | Apr 3, 2018 · 6:25 pm EDT | Form 4 |
| Jeffrey F EisenbergDirector | 64,558 | — | 64,558 | Jan 24, 2018 · 7:13 pm EST | Form 4 |
| Kenneth M CohenDirector | 24,552 | 10,000 | 34,552 | Apr 4, 2018 · 4:15 pm EDT | Form 4/A |
| Michael M WickDirector | 33,551 | 195 | 33,746 | Apr 7, 2015 · 8:39 pm EDT | Form 4 |
| Thomas C VarvaroDirector | 23,063 | — | 23,063 | Apr 3, 2018 · 9:16 pm EDT | Form 4 |
| Paul V MaierDirector | 23,063 | — | 23,063 | Apr 4, 2018 · 6:13 am EDT | Form 4/A |
| Paul F ResnickVICE PRESIDENT, CBO | 18,333 | — | 18,333 | Jan 18, 2018 · 8:00 pm EST | Form 4 |
| Robert HoffmanDirector | 4,438 | — | 4,438 | Apr 4, 2017 · 7:23 pm EDT | Form 4 |
| Jeffrey V. RavetchDirector | 3,086 | — | 3,086 | Apr 4, 2017 · 9:50 pm EDT | Form 4 |
Balances come from each insider’s most recent filing that reports a Table I holding; an insider who left the company years ago still appears with their last-known figure and its date. Indirect totals collapse multiple vehicles (trusts, LLCs) into one number — open the filing for the breakdown. Shares as filed, not split-adjusted.